Plasma Proteomics as a Systemic Monitoring Approach in NSCLC Immunotherapy: Comparative Analysis with ctDNA
Year: 2025
Type: article
Abstract: Background: Real-time, minimally invasive monitoring is critical for optimizing immunotherapy responses in oncology. While circulating tumor DNA (ctDNA) provides direct molecular assessment of tumor burden, plasma proteomics offers complementary systemic insights into tumor biology, immune activation, and tissue damage. We compared plasma proteomic signatures with ctDNA for monitoring response in advanced non-small cell lung cancer (NSCLC).
Source: The Journal of Liquid Biopsy
Authors: Yehuda Brody, Michal Harel, Yehonatan Elon, Shani Raveh Shoval, Adam. P. Dicker, Young Kwang Chae, Ronan Joseph Kelly
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,080
OpenAlex ID: W4416631030
FWCI:
Cites:
Cited by:
Related to: